Mutation profiling for detection of isoniazid resistance inMycobacterium tuberculosisclinical isolates
Open Access
- 25 August 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 70 (12) , 3214-3221
Abstract
Progress in the detection of drug-resistant TB has been underpinned by the development and implementation of new, reliable and rapid diagnostic tools. These rely mostly on the detection of specific mutations conferring resistance to anti-TB drugs. The aim of this study was to search for mutations associated with isoniazid resistance among Mycobacterium tuberculosis clinical isolates. A collection of 150 M. tuberculosis strains, including 50 MDR, 50 isoniazid-monoresistant and 50 pan-susceptible strains, was used. For all the strains, seven structural genes (katG, inhA, ahpC, kasA, ndh, nat and mshA) and two regulatory regions (mabA-inhA promoter and oxyR-ahpC intergenic region) were PCR amplified and sequenced in their entirety. Sixty-six distinct mutations were detected at all nine loci investigated, accounting for 109 (72.7%) of the strains tested. The number of strains with any mutation among the MDR, isoniazid-monoresistant and pan-susceptible groups was 49 (98%), 37 (74%) and 23 (46%), respectively. Mutations in the katG gene predominated, with 29 different types distributed among 46 (92%) MDR, 31 (62%) isoniazid-monoresistant and 2 (4%) pan-susceptible strains. Twenty-nine and 19 mutations were found exclusively in MDR and isoniazid-monoresistant strains, respectively. This study revealed 17 mutations, previously unreported, that might be of potential use as new surrogate markers of isoniazid resistance. Their diagnostic accuracy needs to be confirmed on larger strain samples and from different geographical settings. For isoniazid resistance detection, molecular approaches should still be a complement to rather than a replacement for conventional drug susceptibility testing. This is supported by the lack of mutations in any of the nine genetic loci investigated in 18 isoniazid-resistant strains from this study.Keywords
Funding Information
- ‘Iuventus Plus’
- Polish Ministry of Science and Higher Education (IP2011018771)
This publication has 36 references indexed in Scilit:
- Nosocomial Transmission of Extensively Drug-Resistant Tuberculosis in a Rural Hospital in South AfricaThe Journal of Infectious Diseases, 2012
- Molecular Characterization of Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Strains in Jiangxi, ChinaJournal of Clinical Microbiology, 2012
- Polymorphisms in Isoniazid and Prothionamide Resistance Genes of the Mycobacterium tuberculosis ComplexAntimicrobial Agents and Chemotherapy, 2011
- Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Selection of Mutations To Detect Multidrug-Resistant Mycobacterium tuberculosis Strains in Shanghai, ChinaAntimicrobial Agents and Chemotherapy, 2010
- Biological and Molecular Characteristics of Mycobacterium tuberculosis Clinical Isolates with Low-Level Resistance to Isoniazid in JapanJournal of Clinical Microbiology, 2008
- Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2006
- Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosisPLOS Pathogens, 2006
- Detection of Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis Isolates from ChinaJournal of Clinical Microbiology, 2005
- Characterization of Isoniazid-Resistant Strains of Mycobacterium tuberculosis on the Basis of Phenotypic Properties and Mutations in katGEuropean Journal of Clinical Microbiology & Infectious Diseases, 2001